Immunocompromise and durability of BNT162b2 vaccine against severe outcomes due to omicron and delta variants

Lancet Respir Med. 2022 Jul;10(7):e61-e62. doi: 10.1016/S2213-2600(22)00170-9. Epub 2022 May 6.
No abstract available

Publication types

  • Letter

MeSH terms

  • BNT162 Vaccine*
  • Humans
  • Vaccines*

Substances

  • Vaccines
  • BNT162 Vaccine